Extrait

The primary objectives of this study are to: •Determine the safety and tolerability of MLN1202 in patients with RRMS. •Determine the efficacy of MLN1202 in patients with RRMS by comparing the mean number of new gadolinium-diethylenetriamine pentaacetic acid(Gd)-enhancing lesions on magnetic resonance imaging (MRI) during the pretreatment phase with the mean number of new Gd enhancing lesions found during the treatment phase.

Critère d'inclusion

• The purpose of this study is to investigate the safety, PK parameters, PD responses, and clinical responses of multiple dose administration of MLN1202 in patients with relapsing remitting multiple sclerosis (RRMS)

Liens

• euctr
• euctr
• euctr
• ictrp
• ictrp
• ictrp